Baystate Wealth Management’s Acadia Healthcare ACHC Stock Holding History

Baystate Wealth Management’s Portfolio ACHC Stock Details ACHC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	$1.71K	Buy	+22	New	+$1.63K	﹤0.01%	1091

Other funds holding ACHC

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return

Baystate Wealth Management's ACHC Position: Q4 2023 in Review

Baystate Wealth Management opened a new position in Acadia Healthcare (ACHC) in Q4 2023: 22 shares worth $1.71K. The stake represents ﹤0.01% of the portfolio and ranks #1091 among its holdings.

313 funds tracked by Wall St. Rank hold ACHC as of Q4 2023.

Baystate Wealth Management held 22 shares of Acadia Healthcare worth $1.71K as of Q4 2023.
Acadia Healthcare was a new Baystate Wealth Management position in Q4 2023.
Acadia Healthcare made up ﹤0.01% of Baystate Wealth Management's portfolio in Q4 2023, its #1091 holding.
313 funds tracked by Wall St. Rank held Acadia Healthcare as of Q4 2023.

Based on Baystate Wealth Management's 13F filing for Q4 2023, filed 29 Jan 2024.